Cocrystal Pharma COCP
NASDAQ COCP
$1.20 +0.03 (+2.61%)
As of: Aug 21, 2026 · 11:43 AM EDT

Cocrystal Pharma (COCP) Return on Sales (2010 - 2026)

Cocrystal Pharma (COCP) posted Return on Sales of 0.1% for Q1 2026, down 249.89% sequentially from 0.03% in Q4 2020.

Cocrystal Pharma (COCP) Return on Sales (2010 - 2026) Analysis & Trends

Cocrystal Pharma has reported Return on Sales for 8 years, with the latest figure at 0.1% in Q1 2026.

  • Quarterly Return on Sales changed N/A year-over-year to 0.1% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.05% (changed N/A YoY) and the FY2020 annual result came in at 0.05%, up 3.0% from the prior year.
  • Return on Sales fell to 0.1% in Q1 2026 per COCP's latest filing, from 0.03% in the prior quarter.
  • Over five years, Return on Sales peaked at 0.1% in Q1 2026 and troughed at 0.1% in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Vertex Pharmaceuticals 139.76 Bn 131.91 Bn 2.84 Bn 0.00%
2 Regeneron Pharmaceuticals 86.51 Bn 78.51 Bn 3.93 Bn 0.00%
3 Argenx Se 65.74 Bn 60.56 Bn 1.37 Bn 0.00%
4 Moderna 59.39 Bn 54.26 Bn 52.00 Mn -0.05%
5 BeOne Medicines 42.24 Bn 37.15 Bn 1.53 Bn 0.00%
6 Alnylam Pharmaceuticals 31.78 Bn 28.47 Bn 992.69 Mn 0.00%
7 BioNTech SE 28.65 Bn 10.26 Bn 668.28 Mn 0.00%
8 Insmed 27.58 Bn 26.42 Bn 358.27 Mn 0.00%
9 Royalty Pharma 27.22 Bn 26.39 Bn - 0.00%
10 Cocrystal Pharma 16.27 Mn 13.95 Mn - -0.30%

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.45%
Mar 31, 2026 -0.10%
Dec 31, 2020 -0.03%
Sep 30, 2020 -0.06%
Jun 30, 2020 -0.07%
Mar 31, 2020 -0.06%
Dec 31, 2019 -1.19%
Sep 30, 2019 -0.04%
Jun 30, 2019 -0.03%
Mar 31, 2019 0.01%
Dec 31, 2015 -11.99%
Sep 30, 2015 -0.26%
Jun 30, 2015 -0.93%
Mar 31, 2015 -10.86%
Jun 30, 2013 0.00%
Mar 31, 2013 -0.01%
Dec 31, 2012 0.00%
Sep 30, 2012 0.00%
Jun 30, 2012 0.00%
Mar 31, 2012 -0.01%